scispace - formally typeset
M

Manuel Osorio

Researcher at Center for Biologics Evaluation and Research

Publications -  16
Citations -  647

Manuel Osorio is an academic researcher from Center for Biologics Evaluation and Research. The author has contributed to research in topics: Bacillus anthracis & Ty21a. The author has an hindex of 11, co-authored 16 publications receiving 613 citations.

Papers
More filters
Journal ArticleDOI

Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis

TL;DR: The data unveil multiple pathways by which P. gingivalis may orchestrate chronic inflammation, providing insights into interventional strategies, and identifies immune cell-dependent mechanisms whereby bacterial challenge drives persistent destructive inflammation.
Journal ArticleDOI

Campylobacter jejuni Induces Maturation and Cytokine Production in Human Dendritic Cells

TL;DR: Data indicate that during infection, Campylobacter triggers an innate inflammatory response through increased production of IL-1β,IL-6, IL-8, and TNF-α and initiates a Th1-polarized adaptive immune response as predicted from the high level of production ofIL-12.
Journal ArticleDOI

Cytokine Response to Infection with Bacillus anthracis Spores

TL;DR: It is demonstrated that both mouse peritoneal macrophages and human dendritic cells exhibited significant intracellular bactericidal activity during the first hours following uptake, providing the necessary time to mount a cytokine response prior to cell lysis.
Journal ArticleDOI

Room temperature stabilization of oral, live attenuated Salmonella enterica serovar Typhi-vectored vaccines.

TL;DR: The enhanced heat stability of theTy21a oral vaccine, or Ty21a derivatives expressing foreign antigens (e.g. anthrax), could mitigate risks of vaccine potency loss during long-term storage, shipping, delivery to geographical areas with warmer climates or during emergency distribution following a bioterrorist attack.
Journal ArticleDOI

Anthrax Protective Antigen Delivered by Salmonella enterica Serovar Typhi Ty21a Protects Mice from a Lethal Anthrax Spore Challenge

TL;DR: The ultimate goal is a temperature-stable, safe, oral human vaccine against anthrax infection that can be self-administered in a few doses over a short period of time.